Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma. The ...

Revenue: $83 million in 2024 on a pro forma basis. Cash Balance: Over $600 million, providing runway into 2027. Milestone Payments: $45 million from Sanofi and Roche for achieving technical goals.

In groundbreaking work from The University of Warwick, researchers have found that wild orangutans vocalise with a layered complexity previously thought to be unique to human communication, suggesting ...

Management expressed confidence in achieving further milestones in 2025, supported by partnerships with Roche and Sanofi. CEO Gibson noted that the partnership milestones generated $45 million in cash ...